论文部分内容阅读
目的观察丁苯肽胶囊治疗短暂性脑缺血发作(TIA)的临床疗效。方法选择2005年10月至2008年7月在我科就诊的40例TIA患者,随机分为治疗组(20例)和对照组(20例),治疗组给与丁苯肽200mg,3次/d。对照组仅给予肠溶阿斯匹林100mg,1次/d。疗程为21d。结果治疗组在治疗第7天、第14天、第21天TIA发作控制率分别为40%30%5%明显高于对照组30%20%5%。两组临床疗效比较,治疗组总有效率为75%,对照组总有效率为55%。结论丁苯肽治疗TIA疗效确切,发作控制率明显优于肠溶阿司匹林对照组。
Objective To observe the clinical efficacy of Dingbitu Capsule in the treatment of transient ischemic attack (TIA). Methods Forty TIA patients treated in our department from October 2005 to July 2008 were randomly divided into treatment group (n = 20) and control group (n = 20) d. Control group only given enteric-coated aspirin 100mg, 1 time / d. Treatment for 21d. Results In the treatment group, the control rates of TIA on day 7, day 14 and day 21 were 40%, 30% and 5% respectively, which were significantly higher than those in control group (30%, 20%, 5%). The two groups of clinical efficacy comparison, the total effective rate was 75% in the treatment group, the control group, the total effective rate was 55%. Conclusion Tiabendin is effective in treating TIA, and the control rate of seizures is obviously better than that of enteric-coated aspirin control group.